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Cutaneous T-celllymphoma (CTCL) is a malignancy 
of mature T lymphocytes, most of which express a/(3 
type T-cell receptors (TCRs). The cause of CTCL is 
unknown, but hypotheses postulating chronic stimu-
lation ofTCRs by superantigen or by a leukemogenic 
virus have been proposed. Either mechanism might 
produce bias in the TCR variable (V) region types 
used by the malignant cells. To determine if TCR a 
use is restricted in CTCL, we used reverse transcrip-
tion and the polymerase chain reaction to determine 
Va and V{3 usage by malignant cells purified from the 
peripheral blood of leukemic patients with CTCL. 
Usage of a chain V region segments appeared totally 
random; malignant lymphocytes isolated from each 
of six patients used different V a regions. As has ~een 
C utaneous T-celllymphoma (CTCL) is a malignancy of phenotypically mature T cells that selectively home to the skin [1] . In the early stages of this disease, the m alignant T cells may be confined to the epidermis [2]. With progression, they may form 
tumors within the dermis and can be identifi ed within the circula-
tion . T h e identification of cytologically atypical lymphocytes within 
bo th peripheral blood and erythrodermic skin has been called 
Sezary's syndro me and has been considered evidence of systemic 
involvement in the past [3]. More recent studies, however, have 
determin ed that such cytologic studies may severely underestimate 
the number o f circulatin g malignant cells, and that diminished 
numbers of circulating, non-malignant CDS(+) (normal) T cells 
are associated with a poor prognosis [4]. The residual, "normal" 
cells in th ese patients have not been charactetized. 
C lonality, the detivation of a population of cells from a single 
precursor, is charac teristic of hem atopoietic malignancies [5]. Al-
though clonality in hematologic malignancies was first de termin ed 
by cytogene tic and isoenzyme studies [5] , clonality in lymphoid 
malignancies is now usually established through analysis of specific 
antigen receptors and their genes [6-13]. The T -cell antigen 
receptors (TCR s) are membrane-bound prote in ensembles cen-
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previously reported, no bias was found in {3 chain V 
region usage either. In addition to productive (in 
frame) TCR V region mRNAs in malignant cells from 
~ach patient, we detected non-productive (out of 
frame) {3 chain transcripts in these cells in two of six 
patients, and non-productive 0' chain transcripts in 
five of six. Residual normal peripheral blood lympho-
cytes from these patients showed a random, poly-
clonal or oligoclonal pattern of V region usage. W e 
conclude that there is no bias in V region usage in 
CTCL, making it unlikely that interactions between 
superantigen or virus and the TCR V regions play a 
role in the pathogenesis of CTCL. Key words: T-cell 1 
antigen reaptor!Sezary's syndrome. J Invest Dermato/105:62-
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tered arotmd heterodimers te rrned a:f3 or yo [1 2]. Most T cells, 
including the malignant cells of most CTCLs, use a and (3 
heterodime rs. 
Although they are not truly clonotypic proteins, the TCR a and 
{3 V region proteins ha ve been used as surrogates for the expression 
of clone-specific proteins. Because no particu lar V region would be 
expected to dominate in a random population ofT lymphocytes, 
the demonstration that a large percentage of cells in a given 
lymphoid population use the same V region has been taken as 
presumptive evidence of an expanded clone of cells . Studies using 
anti-V region specific monoclonal antibodies have been useful in 
quantitating, isolating, and characterizing tumor cells on that basis 
in some cases, but th e utility of this approach has been constrained 
by the limited nUJnber ofTCR. V region- specific antibodies that are 
available. Nonetheless, identi ficatio n of putative clones by finding 
restricted use of a single {3 chain variable (V{3) region by CTCL 
tumor cells h as been possible in a small pe rcentage of cases [13-18) . 
More comprehensive analyses of TCR V(3 gene expression have 
been don e utilizi11g RNAse protection assays [19) or reverse 
transcription and eDNA amplification with the polymerase chain 
reaction (PC R.) [20,21] . Although these studies have identifted 
unique patterns of V {3 gene usage by the clone in each individual 
T - cell tumor, no pattern of preferentia l use of a particul ar V/3 
region gene segment by different tumors has been 1·eproducibly 
identified . The number of antibodies available for identifying a 
chain variable region (V a ) usage is e ven more Limited than that 
available for studying V (3, and little is known of TCH .. V a region 
usage in CTCL. 
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To determin e whethe r a cbain variable reg ions are used ran-
domly by tumor cell s in CTCL and to characterize both a and {3 
ch ain usage by residual no rmal c irculating T lymphocytes in 
patients w ith advanced Sezary' s syndrome, w e used monoclonal 
antibodies specific for CD4, CDS, or various TCR V regions to sort 
cells into mal.ignant and n o n-ma l.i gn ant populations. We th en u sed 
the reverse transcription-polymerase cha.in reaction (RT-PCR) 
with Va and V {3 specific prime rs to exa mine these lymp hocyte 
populations for V gene usage . 
MATERIALS AND METHODS 
Patients Patients in tlus study consisted ofsi_-..: CT CL patients between the 
ages of 72 and S2 with erythroderma and with elevated peripheral blood 
T-lymphocyte reactivity for any of the avai lable Vet or V/3 specific 
monoclonal antibodies. 
Monoclonal Antibodies Routine screens of patient periphera l blood 
mononuclear ce lls (PBMLs) were performed witl1 murine monoclonal 
antibodies specific for the C D3, CD4. and C DS cell-surface proteins (Dako 
Corporation, Carpin teria, C A) and TCR a and f3 chains. Murine monoclo-
nal antibodies to human TCR V regions were purchased fro m T-Cell 
D iagnosti cs (Cambridge, MA) [Va2(a) , Vf35(a) , V/35(b). Vf35(c), Vf36(a), 
Vf3S(a), Vf3S(b) . V/31 2(a)J and lmmunotech (Westbrook, ME) (V/32. V/33. 
V/313.3, V/317, V/31 9, V/321. and V/322). 
Analysis and Isolation of Lymphocytes PBMLs were prepared fi·om 
peripheral blood samples, stained. analyzed, and counted as previously 
described [4). For double-labeling. phycoerythrin-conjugated anti-CD4 or 
anti-CDS were used in combination with fluorescein isothiocyanate-labcled 
primary V region specific monoclonal antibodies. Cells were sorted using a 
FacStar 5 (Becton-Dickinson, San Jose. CA) . 
Analysis of TCR Messenger RNA Total RNA was iso la ted using 
Trizol reagent (Gibco, Gaithersburg, MD) and single-stranded copy DNA.~ 
(cDNAs) were made using AMV reverse transcriptase with random hex-
amers as primers (Promega, Madison, W I) . Aliquots of eD NA were 
amplified with 5' primers specific for 22 Vet (T-Cell R eceptor Typing 
Amplimer Kits. C lontech, Palo Alto, CA) and 22 V/3 [22] fi1mities and the 
appropriate Crt or C/3 3' primers (Crt, 5' -AATAGGCAGACAGACTTGT-
CACTGGA; C/3, (a) 5'-CACCAGTGTGGCCTJLTGGGTGTGGG or (b) 
5'- CTGCTTCTGATGGCTCAAACACAGC). PCR products were elec-
trophoresed through 1 .5% agarose ge ls, blotted. probed using digoxigenin-
labeled oligonucleotide probes corresponding to the C region of the a chain 
(5'-GGTCAGGGTTCTGGATAT) or with either a C/3 [5 '-CTGCTTCT-
GATGGCTCAAACACAGC used with C/3 (a) primer) or a consensus V/3 
region probe [5'-TGTAC/TCTCTGTGCCAGCAG used with C/3(b) 
primer) matclung sequence internal to the PCR. primers. Probes were 
detected by chemiluminescence. 
PCR products were subcloned using the In vitrogen TA dolling kit 
(Invitrogen, San Diego, CA). Because multiple col01ucs on an individual 
p late could result from a single tra nsformati onal event during the subclon-
ing process, sequences were not considered clonal unless they were 
reproduced in separa te transformations , and identi fied on separate agar 
plates. Plasmids were purified using Qiagen tips and sequencing was carried 
out by the Keck Foundation Biotechnology R.csource Laboratories (Yale 
U11iversity) . 
RESULTS 
Tbe circulating tumor cells from five patients were reactive with 
V (3-specific m o noclonal antibodies, and those of a sixth patie n t 
reacted with the V a2 monoclo naJ antibody (Table 1). As expec ted , 
V region m essenger RNA (mRNA) detected in the tumor celJs 
corresp onded to the specific V regions ide n tified by monoclonaJ 
antibodies. ln one of the fiv e tumors identified with V {3-specific 
antibodies, additional f3 chain V region mRNAs were ide ntified. 
Seq uen ce ana lysis sh owed th ese additional mRNAs to be the 
products of o u t-of-frame rearran gem en ts and the refore not capable 
of e n coding fun ctional TCR {3 protein . In addition, in the patie n t 
whose tumor cells were reactive with the V a2 monoclonal anti-
body, mRNAs e n coding two {3 variab le regions, 10 and 13.1, w e re 
identified . Of these, only the V /313 .1 mRNAs encoded functio naJ 
V{3 prote in . Thus, two of the si__...: tumors had additionaJ, non-
functio nal V/3 mRNAs presen t. 
In fiv e of the six patients , an in-frame a transcript was identi fied. 
In a sixth pati e n t, whose tumor celJs were identified with a 
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Table I. Tumor Cell Reactivity" 
% of Circula ting V Region-Specific V/3 Region Va Region 
Patient T umor Cells Antibody mRNA m.RNA 
94 f3S V/38 IF Va10 IF 
2 S9 /38 V/38 IF Va13 OF 
3 95 /36 V/36 IF VaS IF 
Va22 OF 
4 79 /36 V/36 IF Va22 IF 
V/37 OF VaS OF 
5 7S /35 V/35 IF Va21 IF 
Va10 OF 
6 70 ct2 V/313.1 IF Va2 IF 
V/310 OF Va3 OF 
'' T he percentage of circulating tumor cc Us w:ts determined by flow cyr.omctry using 
V region-specifi c antibodies and fluore scein isothiocyanatc-labdcd secondary anti-
bodies. mlt.NA ana.lys is was done usin g the reverse rranscriptase-polymcrasc chain 
reaction technique wi th subclcm inJ: and sequencing of the PCR products. Productive 
(in frame) mRNAs arc shown in hold. IF. in fi-a mc: OF. out offi-amc (non-productive). 
V f3S-sp ecific m o n oclonaJ antibody, an out-of- frame V a13 tran-
script was the onJy clonal Va mRNA identified. Jn add,ition, 
mal.ignant cells from fo ur of th e other five patients contain ed 
out-of-fi·ame a transc ripts . T hus, out-of- frame a transcripts were 
identified in maJ.ign an t cells from five of t he six patients in the 
study. Examination of non-ttm1or T cells showed widespread 
representation of a. and f3 chains in both CD4( + ) and CDS(+) 
populations, although the CDS popuJations from some individual s 
showed predominance of several V region types (Fig 1). T hese 
resuJts suggest that no individua l va riab le region is extensively 
utiHzed in responses to these tumors. 
DISCUSSION 
The cau se of CTCL is not known . One hypoth esis is th at chronic 
stimulation by a superantigen found in t he skin ca uses cellular 
proliferation with the opportunity for replicative mistakes resulting 
in tran sformation of a tumor progenitor cell. T h e superantigen-
drive n leuke mogen esis h ypothesis predic ts that the TCRs ex-
pressed by the tumor celJ s would not be randomJy distribu ted 
among a.IJ possible r ecepto r types . A second , related, hypoth esis is 
the receptor-mediated viraJ leukemogenesis hypothesis, w hich 
states th at lymphomas and le ukemias are clonaJ o utg rowth s of 
Va 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 161718 19 20 21 22 
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Figure 1. TCR a chaiu variable region mRNA detection in periph-
eral blood mononuclear cells in a leukemic patient with CTCL. 
Ma.lignant cell s were identified and sorted using a V f3S-specific monoclonal 
antibody. in combination with an anti-CD4 antibody. to isolate Vf3S(-). 
C D4( +) norma] lymphocytes (lap row). and V/38( + ). CD4(+ ) cell s. com-
posed almost exclusively of mal.ignant lr mphocytes (middle rtJII~). CDS(+) 
lymphocytes were screed from tl1e same pa tient and analyzed m a smular 
manner (IJOttmu row). T he V/38(- ) , CD4( + ) nom1al lymphocytes show a 
polyclonal patteru with a fu iJ range ofVct mRNA expression. The Vf3S( + ), 
CD4( + ) malignant lymphocytes show a monoclonal pattern with only a 
single Vet mRNA expressed . T he CDS(+ ), non-tumor lymphocytes show 
an ol.igoclonal pattern with a few dominant Vet mR.NAs expressed. 
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• •those rare cells that use their specific antigen receptors to bind a 
t;ransfonning retrovirus as a11 a11tigeu," thereby stimulating endocy-
tosis and the proliferation of the target cells, and facilitating both 
}Jlfection and transfonnation [23,24]. Such a virus might function as 
a specific antigen or as a superan tigen . In deed, expression of 
specific TCRs reactive with the radiation le ukemia virus (RadL V) 
a ppea r to be characteristic of cells transformed by this agen t; 
preferential usc of the V {36 and V {35 gene segments has been 
i d entified in almost 70 percent of the T -cell tumors induced by this 
agent in C57BL/Ka mice [25]. T hus, viral-mediated leukemogen-
esis has some features of a superantigen-driven process, and the 
RadLV may represent a special superantigen. The superantigen 
stimulation hypothesis and the antigen-receptor mediated vira l 
leukemogenesis hypothesis compete against a third hypothesis 
s tati ng that random occurrence oftransfonnin g events in cutan eous 
lymphoid cells leads to cutaneous T -cell lymphoma . T lus tlurd 
bypothesis predicts random usc of TCR compo nents by tumor 
cells. 
We were abl e to identify five diffe rent a chain variable regions 
osed by tumors of five of the six patients in o ur study. In additio n, 
in the sixth patient, we were able to exclude the possible use of any 
of the 22 a chain variable region fa milies for which we tested . W e 
feel confi.dent in the fin al result in this patie nt, beca use we were 
~ble to identify an out-of-frame a transcript il1 the malignant cells 
:and because examination of RNA isolated from non-malignant 
lymphocytes of the sam e patient, at the sam e tilne, iden tified a fu ll 
s pectrum of transcript types. R epeated examination ofmRNA from 
t hese m alignant cells failed to demonstrate any of th e a variable 
:region types used by other patients' malignancies . The most likely 
explanatio n for this find ing is that this patient's malignant cells use 
a n unknown a variable region th at is not reactive with the primers 
used in th is study. Other explanations are possible, such as the use 
of an a/ 8 hybrid chain [26], a {3/ {3 homodimer [27], or expression 
of a gp33-TCR {3 complex [2S]. R ega rdless o f the expl anation for 
o ur failure to demonstrate an il1-frame a transcript in this patient , 
we can conclusively state that m alignant cells from the six patients 
we examined did not use the same a chain variable regions. When 
o ur results are combm ed with those reported in the literature for 
mali gnant cells from four other CTCL patients [21 ,29], it appears 
that all of the m alignant cells of CTCL examined thus far use 
different a regions. T herefore, there is no bias in TCR a variable 
region usage in the tumors of CTCL W hen these data are 
combined w ith those of the numerous studies reporting no bias il1 
TCR {3 chain use, it appears that TGR variable region usage by 
nulignant cells in CTCL is random. T hus, our results do not 
support the hyp othesis of superantigen stimu lation or of viral 
mediated le ukemogenesis m wlu ch the virus reacts with specific 
variable region components of the a or {3 TCR chams. These 
results, however, do not exclude the possibili ty of a virus as a cause 
of CTCL or the possibili ty of chrmuc stim ulation by a conventional 
antigen contributing to the developm ent of this disease. 
T he fi.ndil1g of dominant bu t random V region usage in the 
C DS(+ ) , non-tumor cells of some patients could represent an 
o ligoclonal response to the m alignant cells. In tlus elderly popula-
tion, however, tlus findmg could also represent the T -cetl equiva-
lent of "benign monoclonal gammapa thy" as bas been described in 
populations of CDS T cells in norm al e lderly humans [30]. In this 
study, populations ofT cells using specifi c V{3 types were fotmd to 
be expanded il1 those T cells expressing the CDS but not the CD4 
surface antigen . Sequencmg studies showed that these expanded 
subpopula tions were o ligoclonal or m onoclonal in nature. 
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